FDA Approves Journavx Drug to Treat Pain Without Addiction Risk NYT > Top Stories By: Gina Kolata 30 January 2025 at 19:12 The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.